ID: ALA4567902

Max Phase: Preclinical

Molecular Formula: C11H10BrN

Molecular Weight: 236.11

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C#CCN1Cc2ccc(Br)cc2C1

Standard InChI:  InChI=1S/C11H10BrN/c1-2-5-13-7-9-3-4-11(12)6-10(9)8-13/h1,3-4,6H,5,7-8H2

Standard InChI Key:  SVFQHRDVRHIUAC-UHFFFAOYSA-N

Associated Targets(Human)

Pyrroline-5-carboxylate reductase 1, mitochondrial 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 236.11Molecular Weight (Monoisotopic): 234.9997AlogP: 2.40#Rotatable Bonds: 1
Polar Surface Area: 3.24Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.24CX LogP: 2.66CX LogD: 2.66
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.68Np Likeness Score: -1.48

References

1. Milne K, Sun J, Zaal EA, Mowat J, Celie PHN, Fish A, Berkers CR, Forlani G, Loayza-Puch F, Jamieson C, Agami R..  (2019)  A fragment-like approach to PYCR1 inhibition.,  29  (18): [PMID:31362921] [10.1016/j.bmcl.2019.07.047]

Source